Anti-diabetic medications and risk of primary liver cancer in persons with type II diabetes

BACKGROUND: Type II diabetes increases liver cancer risk but the risk may be mitigated by anti-diabetic medications. However, choice of medications is correlated with diabetes duration and severity, leading to confounding by indication. METHODS: To address this association, we conducted a nested cas...

Descripción completa

Detalles Bibliográficos
Autores principales: Hagberg, K W, McGlynn, K A, Sahasrabuddhe, V V, Jick, S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4453721/
https://www.ncbi.nlm.nih.gov/pubmed/25093492
http://dx.doi.org/10.1038/bjc.2014.447

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4453721/
https://www.ncbi.nlm.nih.gov/pubmed/25093492
http://dx.doi.org/10.1038/bjc.2014.447

Ejemplares similares